LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | AZD7762 | 0.37 | uM | LJP6 | 72 | hr | 1334 | 3122 | 3925 | 0.7952 | 0.7260 |
BT-20 | AZD8055 | 3.33 | uM | LJP6 | 72 | hr | 1334 | 1391 | 3925 | 0.3546 | 0.0263 |
BT-20 | AT-7519 | 0.04 | uM | LJP6 | 72 | hr | 1334 | 3747 | 3925 | 0.9548 | 0.9411 |
BT-20 | AZD7762 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 3628 | 3925 | 0.9241 | 0.9006 |
BT-20 | AZD8055 | 0.04 | uM | LJP6 | 72 | hr | 1334 | 2367 | 3925 | 0.6035 | 0.4440 |
BT-20 | AZD8055 | 1.11 | uM | LJP6 | 72 | hr | 1334 | 1506 | 3925 | 0.3839 | 0.0810 |
BT-20 | Seliciclib | 0.37 | uM | LJP5 | 72 | hr | 1334 | 3825 | 4033 | 0.9490 | 0.9358 |
BT-20 | Seliciclib | 10 | uM | LJP5 | 72 | hr | 1334 | 1724 | 4033 | 0.4276 | 0.1737 |
BT-20 | AT-7519 | 1.11 | uM | LJP6 | 72 | hr | 1334 | 854 | 3925 | 0.2177 | -0.2501 |
BT-20 | AZD7762 | 0.04 | uM | LJP6 | 72 | hr | 1334 | 4096 | 3925 | 1.0433 | 1.0540 |
BT-20 | AZD7762 | 3.33 | uM | LJP6 | 72 | hr | 1334 | 1438 | 3925 | 0.3665 | 0.0491 |
BT-20 | AZD7762 | 10 | uM | LJP6 | 72 | hr | 1334 | 417 | 3925 | 0.1064 | -0.5260 |
BT-20 | AZD8055 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 1948 | 3925 | 0.4964 | 0.2749 |
BT-20 | AZD8055 | 0.37 | uM | LJP6 | 72 | hr | 1334 | 1601 | 3925 | 0.4082 | 0.1234 |
BT-20 | Seliciclib | 0.04 | uM | LJP5 | 72 | hr | 1334 | 4094 | 4033 | 1.0156 | 1.0199 |
BT-20 | Seliciclib | 0.12 | uM | LJP5 | 72 | hr | 1334 | 4007 | 4033 | 0.9941 | 0.9928 |
BT-20 | Seliciclib | 1.11 | uM | LJP5 | 72 | hr | 1334 | 3827 | 4033 | 0.9489 | 0.9352 |
BT-20 | Seliciclib | 3.33 | uM | LJP5 | 72 | hr | 1334 | 3442 | 4033 | 0.8529 | 0.8091 |
BT-20 | AT-7519 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 3834 | 3925 | 0.9770 | 0.9701 |
BT-20 | AT-7519 | 0.37 | uM | LJP6 | 72 | hr | 1334 | 3020 | 3925 | 0.7695 | 0.6901 |
BT-20 | AT-7519 | 3.33 | uM | LJP6 | 72 | hr | 1334 | 350 | 3925 | 0.0894 | -0.5784 |
BT-20 | AT-7519 | 10 | uM | LJP6 | 72 | hr | 1334 | 285 | 3925 | 0.0728 | -0.6302 |
BT-20 | AZD7762 | 1.11 | uM | LJP6 | 72 | hr | 1334 | 2258 | 3925 | 0.5752 | 0.4018 |
BT-20 | Sorafenib | 0.04 | uM | LJP6 | 72 | hr | 1334 | 3776 | 3925 | 0.9620 | 0.9506 |
BT-20 | AZD8055 | 10 | uM | LJP6 | 72 | hr | 1334 | 1052 | 3925 | 0.2681 | -0.1421 |